Clinical Trial Update: A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo [Phase 1]

View source ↗

Summary

This document provides a Phase 1 proof-of-concept trial update for CGB-600 as a topical treatment for vitiligo, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• CGB-600

Snippet

Sponsor: CAGE Bio Inc. | Conditions: Vitiligo | Phase 1 | Status: RECRUITING